PhRMA positive on change in Japan but keeps up pressure for more
This article was originally published in SRA
Executive Summary
US innovator pharmaceutical industry association PhRMA has welcomed regulatory and pricing changes in Japan but wants to see further policy reforms that it believes would better support the development of novel drugs.